To access this element change to forms mode OFF
Grant Award View - GA187356
Statins and Progression of Coronary Atherosclerosis in Melanoma Patients...
GA ID:
GA187356
Agency:
Department of Health and Aged Care
Approval Date:
11-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
11-Jun-2021 to 31-May-2025
Value (AUD):
$1,669,300.28
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
MRFF_2020_Cardiovascular_Health_Mission
Grant Activity:
Statins and Progression of Coronary Atherosclerosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors
Purpose:
Checkpoint inhibitors are used in an increasing number of melanoma patients. Recent data has suggested that checkpoint inhibitor use may associate with both a greater risk of heart attack and stroke, which may relate to greater growth of plaques in blood vessels. In this clinical trial we will compare the effects of statins (drugs commonly used to lower cholesterol) and placebo on plaque growth in melanoma patients treated with checkpoint inhibitors.
GO ID:
GO Title:
MRFF – Cardiovascular Health Mission – 2020 Cardiovascular Health Grant Opportunity
Internal Reference ID:
MRF2008437
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA